Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Frontiers in Immunology Année : 2016

Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention

Résumé

Tertiary lymphoid structures (TLS) are ectopic lymphoid aggregates that reflect lymphoid neogenesis occurring in tissues at sites of inflammation. They are detected in tumors where they orchestrate local and systemic anti-tumor responses. A correlation has been found between high densities of TLS and prolonged patient's survival in more than 10 different types of cancer. TLS can be regulated by the same set of chemokines and cytokines that orchestrate lymphoid organogenesis and by regulatory T cells. Thus, TLS offer a series of putative new targets that could be used to develop therapies aiming to increase the anti-tumor immune response.
Fichier principal
Vignette du fichier
fimmu-07-00407.pdf (238.39 Ko) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-01388151 , version 1 (26-10-2016)

Licence

Paternité

Identifiants

Citer

Catherine Fridman, Myriam Lawand, Nicolas A. Giraldo, Hélène Kaplon, Claire Germain, et al.. Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention. Frontiers in Immunology, 2016, 7, pp.407. ⟨10.3389/fimmu.2016.00407⟩. ⟨hal-01388151⟩
444 Consultations
171 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More